Reaching People, Changing Lives with Innovative Medications

Aurinia is a late-stage biopharmaceutical company providing novel products specifically engineered to treat a limited, targeted patient population suffering from serious disease states for which there is a high unmet medical need.

Our mission is to develop and deliver treatments to people suffering from debilitating diseases.

Leadership Backed by a Century of Industry Experience

Our highly skilled leadership team has a proven track record of success in targeted markets. Together they possess more than 100 years of combined corporate and industry specific experience. Our strategy leverages the skills and knowledge of our team’s past clinical experience in the treatment of lupus.